LP Pharmaceuticals Funding: $102M Raised, Series C (2020)
LP Pharmaceuticals is based in Burlingame, California. It has raised $102M in total funding. Latest round: Series C.
LP Pharmaceuticals funding overview
LP Pharmaceuticals is based in Burlingame, California. LP Pharmaceuticals has raised $102M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in August 2020. The round record for LP Pharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include Sequoia Capital China, SDIC Innovation. 2 distinct backers are named across the disclosed rounds.
LP Pharmaceuticals at a glance
Total raised
$102M
Latest round
Series C
Latest round date
August 2020
Headquarters
Burlingame, California
Notable investors
Sequoia Capital China, SDIC Innovation
Frequently asked about LP Pharmaceuticals funding
How much has LP Pharmaceuticals raised?
LP Pharmaceuticals has raised $102M in total disclosed funding across the rounds on record.
Who has invested in LP Pharmaceuticals?
Sequoia Capital China, SDIC Innovation are named among the investors backing LP Pharmaceuticals.
What was the latest LP Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in August 2020.
Where is LP Pharmaceuticals based?
LP Pharmaceuticals is based in Burlingame, California.
When did LP Pharmaceuticals last raise?
The last disclosed LP Pharmaceuticals round closed in August 2020 at Series C.
LP Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Burlingame below to benchmark round size and investor mix.
